Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05115292
Title A First-in-Human, Phase 1 Dose-Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BJ-005 in Patients With Advanced Solid Tumor or Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors BJ Bioscience, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic - Phoenix Phoenix Arizona 85054 United States Details
Mayo Clinic - Florida Jacksonville Florida 32224 United States Details
Hematology/Oncology Assoc. of the Treasure Coast Port Saint Lucie Florida 34952 United States Details
Mayo Clinic - Rochester Rochester Minnesota 55905 United States Details
Carolina BioOncology Huntersville North Carolina 28078 United States Details
Next Oncology Austin Texas 78758 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field